New protein target offers promise for alleviating cognitive decline in Parkinson’s disease

A recently published study by researchers at the University of Arizona Health Sciences found that a tiny protein called PNA5 appears to have a protective effect on brain cells, which could lead to treatments for the cognitive symptoms of Parkinson’s disease and related disorders.

Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness through Cedar Clinical Research – Psychedelic Alpha

VANCOUVER, BC, Oct. 3, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF) – a mental health care company advancing innovative

October 3, 2023

Toripalimab by Shanghai Junshi Biosciences for Metastatic Colorectal Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

November 19, 2023

The top medtech trends in 2024

The medical device industry is set up for an eventful year after weathering numerous challenges for the past four years due to the COVID-19 pandemic

January 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.